Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 12:48 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 1,104,904 8.132% | -410,678 (-27.10%) | View |
| 2023-02-03 5:15 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Farallon Capital Partners L.P. | 1,417,917 9.99% | 1,417,917 (New Position) | View |
| 2023-01-25 4:38 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | INTEGRATED CORE STRATEGIES (US) LLC | 987,712 7.3% | 212,232 (+27.37%) | View |
| 2022-03-21 4:25 pm Purchase | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 3,978,540 23.1% | 3,978,540 (New Position) | View |
| 2022-03-10 4:43 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | ARENA PHARMACEUTICALS INC ARNA | 3,978,540 23.1% | 3,978,540 (New Position) | View |
| 2022-02-14 3:16 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 1,381,932 9.99% | 42,301 (+3.16%) | View |
| 2022-02-14 2:35 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | PRICE T ROWE ASSOCIATES INC | 2,024,616 14.9% | -278,133 (-12.08%) | View |
| 2022-02-09 09:22 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 1,515,582 11.155% | -477,554 (-23.96%) | View |
| 2022-02-03 09:10 am Unchanged | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FARALLON CAPITAL MANAGEMENT LLC | 810,500 6% | 0 (Unchanged) | View |
| 2022-01-12 4:25 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | INTEGRATED CORE STRATEGIES (US) LLC | 775,480 5.7% | 775,480 (New Position) | View |
| 2021-04-12 2:07 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | PRICE T ROWE ASSOCIATES INC | 2,302,749 17.3% | 2,302,749 (New Position) | View |
| 2021-04-12 1:05 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 1,993,136 14.999% | 1,993,136 (New Position) | View |
| 2021-03-26 4:05 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 1,339,631 9.99% | 1,339,631 (New Position) | View |
| 2021-03-24 6:35 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FARALLON CAPITAL MANAGEMENT LLC | 810,500 6.1% | 810,500 (New Position) | View |
| 2021-03-22 4:23 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | HBM Healthcare Investments (Cayman) Ltd. | 1,327,430 9.99% | 1,327,430 (New Position) | View |